U.S. Food Stock News

Super Group (SGHC) recently reported first-quarter 2026 results, with revenue rising to US$612 million and net income to US$87 million, while reaffirming full-year 2026 guidance targeting at least US$2.55 billion in total revenue. The company also shifted to a new Africa and International segment reporting structure and is stepping up investor outreach through multiple May 2026 conferences and roadshows, giving investors clearer regional transparency and more access to management. We’ll now...

In early May 2026, ADMA Biologics reported first-quarter 2026 results showing essentially flat sales at US$114.49 million year over year, but net income rose to US$45.33 million and earnings per share increased to US$0.19, alongside updated full-year 2026 revenue guidance of US$530 million to US$560 million. Around the same time, the FDA approved an expanded label for ASCENIV to include pediatric primary humoral immunodeficiency patients as young as two years old, while short seller-driven...

Somnigroup International Inc. reported past first-quarter 2026 results with sales of US$1,801.5 million and net income of US$104.2 million, and affirmed a quarterly dividend of US$0.17 per share. The swing from a prior-year net loss to profit, alongside continued dividend payments, highlights a shift in profitability and capital return priorities. We'll now examine how Somnigroup's earnings beat, revenue shortfall, and reaffirmed full-year guidance affect its existing investment narrative...

Earlier this week, Sonida Senior Living, Inc. completed a US$19.41 million at-the-market follow-on equity offering of common stock at per-share prices of US$27.50 and US$32.00, shortly after reporting first-quarter 2026 revenue of US$122.63 million and a net loss of US$41.23 million. The company’s update highlighted rising same-store occupancy and higher margins following the CNL Healthcare Properties acquisition, even as losses widened, pointing to an early but complex integration phase...

Q1 earnings surprise and renewed analyst attention Colgate-Palmolive (CL) recently reported Q1 results with both revenue and earnings ahead of analyst expectations, prompting fresh attention on the stock as you consider how its fundamentals compare after the surprise. See our latest analysis for Colgate-Palmolive. The share price has moved around Q1 and dividend news, with a 30-day share price return of 2.70% and a year to date share price gain of 13.44%, while the 1-year total shareholder...

Compass, Inc. reported first-quarter 2026 results showing sales of US$2,704 million versus US$1,356 million a year earlier and net income of US$22 million, alongside issuing second-quarter revenue guidance of US$4.0 billion to US$4.2 billion. Management attributed the improved performance to rapid integration of the Anywhere acquisition, realizing over US$250 million of cost synergies within just 82 days of closing and signaling momentum across mortgage, title, and core brokerage...

Investors may be wondering whether Tractor Supply at US$30.57 is starting to look interesting, or if the market is still reassessing what the stock is really worth. The share price is down 0.3% over the past week, 32.1% over the past month and 39.9% year to date, with a 41.3% decline over the last year and a 28.2% drop over three years. This suggests that investors have been rethinking the risk and reward trade off. These moves come alongside a broader reassessment of the retail sector and...

Alibaba Group Holding Limited has reported its fiscal 2026 results, with March-quarter revenue rising to CNY 243,380 million and net income to CNY 25,541 million, while full-year revenue reached CNY 1.02 trillion but net income declined to CNY 103,592 million alongside weaker earnings per share. Alongside these mixed earnings, Alibaba is sharply increasing AI and cloud investment, growing AI-related cloud revenue to 30% of external cloud sales and affirming an annual dividend of US$1.03 per...

Wondering if AES at around US$14.47 offers good value today? This article walks through what the current price might be implying about the stock. The share price is up 1.0% over the past week, flat over the past month, down 2.4% year to date, and up 24.6% over the past year, which can leave the current risk and reward trade off feeling unclear. That mixed return profile sits against ongoing investor interest in utilities and renewables, where sentiment can shift quickly as capital flows in...

Why Invitation Homes (INVH) is on investors’ radar Invitation Homes (INVH) has drawn fresh attention after recent share price moves, with the stock closing at US$27.93. Investors are weighing this level against the company’s current fundamentals and longer term return profile. See our latest analysis for Invitation Homes. Recent trading reflects a mixed picture, with the share price down 1.93% over the last session and the 1-year total shareholder return declining 15.38%. However, the 3-month...

Dutch Bros Coffee has already opened its first Chicago-area drive-thru in Melrose Park and is rolling out additional Illinois locations as part of a broader Midwest expansion, while reporting first-quarter 2026 revenue of US$464.41 million and net income of US$16.1 million. This mix of entering a major new market and raising full-year 2026 revenue guidance to between US$2.05 billion and US$2.08 billion adds fresh context to how Dutch Bros is trying to scale its brand and operations...

If you are wondering whether SLB is still reasonably priced after a strong run, the next sections walk through how its current share price compares with different valuation yardsticks. SLB shares last closed at US$55.38, with returns of 4.0% over the past week, 5.2% over the past month, 37.8% year to date, and 59.6% over the past year. This puts recent performance front and center for any value check. Recent coverage has focused on SLB's position within the wider energy services sector and...

In early May 2026, Fortinet announced it is accelerating its FortiAIGate solution with NVIDIA’s AI platforms to secure AI workloads, data, and autonomous agents across data centers, cloud, and edge environments while supporting data sovereignty and zero-trust principles. This collaboration positions FortiAIGate as a specialized layer for runtime guardrails and GPU-accelerated protection of large language models and AI agents, potentially deepening Fortinet’s role in safeguarding enterprise...

Assessing whether Kroger at around US$66 per share still offers value, or whether most of the opportunity is already reflected in the price, begins with understanding what that current price represents. The stock is up 0.6% over the last week and 4.9% year to date, but has declined 3.2% over the last month and is down 2.1% over the past year, which can influence how investors think about both upside potential and risk. Recent attention on Kroger has focused on its position in U.S. grocery...

Corteva, Inc. recently reported first-quarter 2026 results, with sales of US$4,905 million and net income of US$720 million, alongside reaffirmed full-year operating EPS guidance of US$3.45 to US$3.70. At the same time, Corteva completed a share repurchase of 11,508,031 shares for US$819.95 million under its November 2024 buyback program, highlighting continued capital returns to shareholders. With Corteva reaffirming its 2026 operating EPS outlook, we’ll now examine how this confidence in...

Earlier this month, Alphabet completed a record-breaking ¥576.5 billion (about US$3.60 billion) multi‑tranche yen bond sale, part of nearly US$60.00 billion raised recently in global debt markets to fund AI infrastructure, data centers and cloud capacity. This financing push sits alongside product moves like the upcoming Googlebook AI laptop and large Google Cloud commitments, underscoring Alphabet’s push to be core infrastructure for the growing AI economy. Next, we’ll examine how this...

Recent share performance and valuation snapshot Kontoor Brands (KTB) has drawn attention after a recent pullback, with the stock down about 20% over the past month and roughly 8% over the past 3 months. This has sharpened investor focus on fundamentals. At a recent close of US$61.76 and a market value near US$3.4b, the company screens with a value score of 5 and an intrinsic discount estimate of about 27%. This has prompted closer scrutiny of its earnings power and cash generation. See our...

In recent months, analysts at JPMorgan and DA Davidson downgraded A. O. Smith after the company cut guidance, citing softer North American residential demand and mounting weakness in its China operations. This reassessment highlights how A. O. Smith’s reliance on residential markets and exposure to a pressured Chinese consumer can weigh on confidence in its growth plans. We’ll now examine how these China-related concerns may affect A. O. Smith’s previously optimistic investment narrative...

Wondering whether Palo Alto Networks at around US$242.83 is offering fair value or stretching expectations, especially after such a strong run, is a natural question for any investor sizing up the stock today. The share price moves help frame that question, with returns of 16.8% over the past week, 44.7% over the past month, 35.4% year to date and 25.8% over the last year. The 3 year return stands at 157.4% and the 5 year return at 302.0%. Recent headlines have focused on Palo Alto Networks...

Recent performance snapshot Autohome (NYSE:ATHM) has recently caught investor attention after a period of weaker share performance, with the stock down 3.7% over the past day and 10.3% over the past week. Those short term moves add to declines of 8.9% over the past month and 18.8% over the past 3 months, with the stock also down 24.8% year to date and 28.4% over the past year. See our latest analysis for Autohome. With the share price at US$17.05 and weaker recent share price returns,...

Context on Bicara Therapeutics Bicara Therapeutics (BCAX) has drawn investor attention recently as a clinical stage biopharmaceutical company focused on bifunctional therapies for solid tumors. Its lead program, ficerafusp alfa, targets epidermal growth factor receptor and transforming growth factor beta. See our latest analysis for Bicara Therapeutics. Bicara Therapeutics' share price has eased recently, with the 7 day share price return down 10.41% and the 30 day share price return down...

Investors may be asking whether Gentex at around US$22.87 is offering good value right now, or if the stock is fairly priced based on what the business is delivering. The share price has slipped about 2.2% over the past week, is up 1.1% over the last month, and is still down 3.5% year to date, with a modest 1.2% gain over the last year. Recent attention has focused less on fresh headlines and more on how Gentex fits into investor portfolios at its current price, especially given its longer...

In mid-May 2026, Globant S.A. reported first-quarter 2026 results showing sales of US$607.09 million, slightly below the prior year, but higher net income and earnings per share, alongside new guidance that implies broadly flat revenue for the second quarter and low single-digit growth for full-year 2026. The company also completed a US$125 million buyback and launched a new US$125 million repurchase program, underscoring management’s emphasis on capital returns while it accelerates its...

Stock performance snapshot G-III Apparel Group (GIII) has been under pressure recently, with the stock down 3.4% on the day, 9.6% over the past week, and 5.8% over the past month. Over the past 3 months the share price declined 4.7%, while the year-to-date move is a 2.6% decline. Even so, the 1-year total return stands at 2.8%, and the 3-year total return is about 7.6 times. See our latest analysis for G-III Apparel Group. With the share price at $28.73 and recent share price returns weaker...